
Aurora is transforming personalized gene editing from a one-patient breakthrough into a scalable platform capable of bringing therapies to millions of patients with rare diseases.
-
2025 - Founded; incubated by Menlo Ventures
Leadership

Edward M Kaye, M.D.
CEO

Jennifer Doudna, Ph.D.
Co-Founder

Fyodor Urnov, Ph.D.
Co-Founder


